ANTIBODIES AGAINST FACTOR XII / XIIA AND THEIR USES

MA52966AUndetermined Publication Date: 2021-04-28REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA52966
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-06-19
Filing Date
2019-06-19
Publication Date
2021-04-28
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.